PALAZZOLO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 6.929
AS - Asia 6.515
EU - Europa 6.477
Continente sconosciuto - Info sul continente non disponibili 707
SA - Sud America 562
AF - Africa 144
OC - Oceania 50
Totale 21.384
Nazione #
US - Stati Uniti d'America 6.657
IT - Italia 2.181
SG - Singapore 1.920
CN - Cina 1.917
DE - Germania 1.082
GB - Regno Unito 1.018
BD - Bangladesh 538
VN - Vietnam 534
HK - Hong Kong 524
SE - Svezia 507
BR - Brasile 423
RU - Federazione Russa 371
IN - India 298
FR - Francia 297
JP - Giappone 206
NL - Olanda 203
CA - Canada 160
KR - Corea 145
ID - Indonesia 143
FI - Finlandia 133
IE - Irlanda 125
DK - Danimarca 123
BE - Belgio 71
AT - Austria 54
TR - Turchia 54
CI - Costa d'Avorio 52
CH - Svizzera 49
PL - Polonia 47
ES - Italia 45
MX - Messico 45
AR - Argentina 43
AU - Australia 43
UA - Ucraina 30
IQ - Iraq 27
TW - Taiwan 27
EC - Ecuador 26
PK - Pakistan 22
PT - Portogallo 22
IR - Iran 21
CO - Colombia 20
CZ - Repubblica Ceca 20
PH - Filippine 20
CR - Costa Rica 19
GR - Grecia 19
ZA - Sudafrica 19
VE - Venezuela 17
NO - Norvegia 16
TN - Tunisia 15
EG - Egitto 14
MY - Malesia 13
TH - Thailandia 13
IL - Israele 12
UZ - Uzbekistan 12
CL - Cile 10
MA - Marocco 10
SC - Seychelles 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
SA - Arabia Saudita 8
BG - Bulgaria 7
HU - Ungheria 7
JM - Giamaica 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
LT - Lituania 6
LU - Lussemburgo 6
NZ - Nuova Zelanda 6
PE - Perù 6
PY - Paraguay 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
LK - Sri Lanka 4
NI - Nicaragua 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
LB - Libano 3
NG - Nigeria 3
NP - Nepal 3
PR - Porto Rico 3
BB - Barbados 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CM - Camerun 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GD - Grenada 2
GH - Ghana 2
HN - Honduras 2
Totale 20.636
Città #
Singapore 1.120
Ashburn 850
Milan 784
Southend 769
Frankfurt am Main 593
Hong Kong 456
San Jose 431
Dallas 393
Council Bluffs 307
Santa Clara 301
Beijing 280
Fairfield 267
Chandler 261
Hefei 226
Hanoi 225
Los Angeles 205
Wilmington 205
Seattle 172
Cambridge 160
New York 158
Ann Arbor 154
Houston 141
Woodbridge 131
Ho Chi Minh City 124
Dublin 122
Princeton 117
Redwood City 112
Bengaluru 109
Dearborn 109
Jakarta 98
Tokyo 96
Rome 91
Hanover 90
Lauterbourg 86
Seoul 84
Buffalo 78
Moscow 78
Shanghai 76
Boardman 74
The Dalles 74
Guangzhou 70
Helsinki 69
Nanjing 69
Phoenix 62
Munich 59
Abidjan 52
Grafing 52
Chicago 50
Naples 47
Columbus 43
Cangzhou 41
Des Moines 39
Amsterdam 35
Medford 31
Vienna 30
Montreal 29
São Paulo 29
Berlin 28
Tianjin 28
Toronto 28
Warsaw 28
Jinan 27
Nuremberg 27
Dong Ket 26
Ponte San Pietro 26
Shenyang 26
Bologna 24
Changsha 24
Hebei 24
Istanbul 24
London 22
Turin 22
Hangzhou 21
Nanchang 21
Boston 20
Brussels 20
Shenzhen 20
Lappeenranta 19
Orem 19
Wuhan 19
Atlanta 18
Cinisello Balsamo 18
Düsseldorf 18
Melbourne 18
Rho 18
Zhengzhou 18
Florence 17
Turku 17
Braine-l'Alleud 16
Chengdu 16
Liège 16
Mumbai 16
Washington 16
Bari 15
Basingstoke 15
Belo Horizonte 15
Bühl 15
Da Nang 15
Fuzhou 15
San Diego 15
Totale 11.884
Nome #
With or without you - Proteomics with or without major plasma/serum proteins 651
DEVELOPMENT OF AN INTEGRATED IN SILICO STRATEGY FOR THE RISK ASSESSMENT OF CHEMICALS AND THEIR MIXTURES ON DIFFERENT TOXICOLOGICAL OUTCOMES. 500
SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure 440
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5) : probing critical residues for substrate translocation 435
Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand 426
Comparison of Protein Design Tools For Engineering Non-heme Iron Dependent Dioxygenases 390
A promiscuous recognition mechanism between GPR17 and SDF-1 : molecular insights 383
Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity 347
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 343
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease 325
In silico description of LAT1 transport mechanism at an atomistic level 319
2,4-Furfurylidene-D-sorbitol and its tetra-methyl ether: Synthesis, conformational studies, and radical scavenging activity 317
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 315
Development of an adverse outcome pathway for cranio-facial malformations: A contribution from in silico simulations and in vitro data 314
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach 305
Atomistic description of the OCTN1 recognition mechanism via in silico methods 295
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 294
Deciphering and modelling remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties 291
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 284
Computational modelling of the LCAT::rHDL complex and bases of LCAT pharmacological activation 281
rHDL modelling and the anchoring mechanism of LCAT activation 278
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 270
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 270
Structural investigation and molecular modeling studies of strobilurin-based fungicides active against the rice blast pathogen Pyricularia oryzae 270
Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism 266
Comparison of teratogenic potency of azoles using in silico and in vitro methods 257
Exploration of Novel Scaffolds Targeting Cytochrome b of Pyricularia oryzae 253
What if? Mouse proteomics after gene inactivation 251
Distinguishing mode of action of compounds inducing craniofacial malformations in zebrafish embryos to support dose-response modeling in combined exposures 250
Predicting estrogen receptor binding of chemicals using a suite of in silico methods – Complementary approaches of (Q)SAR, molecular docking and molecular dynamics 247
GPR17 molecular modelling: interactions with non-conventional pro-inflammatory ligands 245
Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells 244
Gender proteomics. II. Which proteins in sexual organs 241
Discovery and characterization of a new class of NAD+-independent SIRT1 activators 238
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 234
In silico investigation on structure–function relationship of members belonging to the human SLC52 transporter family 232
Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence 230
Hemolymph proteins: An overview across marine arthropods and molluscs 226
Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder 223
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 223
Development of an integrated system biology model for predicting mixtures of chemicals: the case of the azole fungicides 222
Deciphering the ligand/xenobiotic molecular recognition mechanism in SLC transporters via a new structural binding site analysis 218
SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability 215
Mechanism of LAT1 amino acid antiporter: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 215
In silico prioritization of endocrine active substances (EAS) and their in vitro validation 214
Effect of Fc core fucosylation and light chain isotype on IgG1 flexibility 210
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 206
Analisi geofisica integrata per la caratterizzazione della micrometeorologia ipogea 204
Supramolecular modeling of an LCAT-rHDL assembly and cholesterol transesterification mechanism 198
In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3 196
GM1 structural requirements to mediate neuronal functions 195
Modellng Molecolare e meccanismo di interazione del complesso LCAT-rHDL 195
Investigation of in silico studies for cytochrome P450 isoforms specificity 191
Differential skeletal preservation between sexes: a diachronic study in Milan over 2000 years 190
L'approccio in silico 189
A new strategy for selective NOTCH2 targeting in multiple myeloma based on small molecules hampering receptor-ligand interaction 188
In silico prioritization for endocrine active substances (EAS) and their in vitro validation 187
Some more about dogs: Proteomics of neglected biological fluids 185
Gender proteomics I. Which proteins in non-sexual organs 183
Valutazione in silico dell’attività tossica di beta-insect depressant toxin LqhIT2 prodotta da Leiurus hebraeus sui canali voltaggio- dipendenti del sodio di Homo Sapiens 182
In silico Investigation on Structure–Function Relationship of Members Belonging to the Human SLC52 Transporter Family 180
In silico description of OCTN1 recognition mechanism and the role of sodium in substrate binding 179
Predicting Estrogen receptor binding of chemicals using a suite of in silico methods : complementary approaches of (Q)SAR, Molecular Docking and Molecular Dynamics 177
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 173
Supramolecular modelling of an LCAT-rHDL assembly and cholesterol trans- esterification mechanism 172
The diachronic trend of female and male stature in Milan over 2000 years 171
Literature search – Exploring in silico protein toxicity prediction methods to support the food and feed risk assessment 169
In silico investigation of mAbs conformational changes upon antigen binding: impact of glycosylation and light chain isotype 165
In Silico Prediction Tools for Cytochrome P450 Isoform Specificity: A Comprehensive Review and Model Evaluation 165
Development of in silico methodologies to predict the toxicity of novel proteins in the context of food and feed risk assessment 163
From Protein Toxins to Applied Toxicological Testing 162
New Notch-targeted therapeutic strategy to uncouple a pathological interaction of myeloma cells and bone marrow microenvironment using novel small molecules 159
Insights into the EFSA protein risk assessment: in silico tools : Protein toxicity: an integrated in silico pipeline 154
In silico prediction of ANGPTL3-endothelial lipase interaction 150
In silico identification of small molecules engaging the TNFR2-TNF-α interaction: a novel approach for targeting demyelinating diseases 150
Sviluppo e validazione di una pipiline integrata in silico per la determinazione di affinità e attività intrinseca di xenobiotici sul recettore alfa degli estrogeni 147
Supramolecular modelling of an LCAT-rHDL assembly and cholesterol trans- esterification mechanism 145
An in silico integrated pipeline for affinity and intrinsic activity evaluation of estrogen receptor alpha putative ligands 143
In silico description of OCTN1 recognition mechanism and the role of sodium in substrate binding 140
Biological and molecular characterization of in silico identified putative inhibitors of paraspeckle assembly with potential anti-multiple myeloma activity 140
Predicting estrogen receptor binding of chemicals using a suite of in silico methods-complementary approaches of (Q)Sar, molecular docking and molecular dynamics 137
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 136
In silico identification of small molecules engaging the TNFR2-TNF-α interaction: a novel approach for targeting demyelinating diseases 134
Structure-activity and molecular modeling studies of strobilurin-based dual fungicides for the control of rice blast pathogen Pyricularia oryzae 131
LAT1, a pivotal actor on cancer stage: when function meets structure 116
Modelli QSAR e Approcci Read-Across: Strumenti Fondamentali per la Valutazione del Rischio 111
In silico prediction of ANGPTL3-EL interaction 104
Strategie in silico di predizione di tossicità applicate alle proteine 104
From Protein Toxins to Applied Toxicological Testing Virtual Workshop Identifies the Need for a Bioinformatic Framework to Assess Novel Food Protein Safety 99
AOP-based experimental models to evaluate effects of azole mixtures 95
Protective and reparative effects of fluconazole on neuronal differentiation altered by 5HT 93
A new "old" model: PBPK 93
Stato dell'arte sugli strumenti in silico per la predizione di tossicità di proteine 90
Ragionare è nient'altro che calcolare 88
La fisica degli archivi del tempo 75
Development of a predictive in silico model for mixtures of azole fungicides acting on the skeletal craniofacial AOP 74
Tutti i modelli sono sbagliati, ma alcuni sono utili 71
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 65
Exercise with PB-PK models 58
From Sequence to Structure: pros and cons of AlphaFold-Based Modeling 38
Totale 21.302
Categoria #
all - tutte 61.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.206 0 86 100 98 73 93 78 73 76 131 136 262
2022/20231.430 187 107 107 122 128 223 68 116 155 47 105 65
2023/20241.922 66 105 235 245 312 74 144 153 65 127 170 226
2024/20253.759 181 383 164 347 280 150 215 369 195 331 321 823
2025/20267.738 703 640 822 700 637 402 905 311 739 495 799 585
2026/20271.024 516 508 0 0 0 0 0 0 0 0 0 0
Totale 21.384